Fulgent Genetics (FLGT) IPO Opens Modestly Higher
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Today's IPO for Fulgent Genetics (Nasdaq: FLGT) opened for trading at $9.21 after pricing its initial public offering of 4,200,000 shares of its common stock at a public offering price of $9.00 per share, the low end of the expected range.
Credit Suisse Securities (USA) LLC and Piper Jaffray & Co. are serving as joint book-running managers for the offering. Raymond James & Associates, Inc. is serving as lead manager and BTIG, LLC is serving as co-manager.
Fulgent Genetics is a rapidly growing technology company with an initial focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. The company developed a proprietary technology platform that integrates sophisticated data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. This platform allows us to offer a broad and flexible test menu while maintaining accessible pricing, high accuracy and competitive turnaround times. Fulgent Genetics believes its current test menu offers more genes for testing thancompetitors in today’s market, which enables them to provide expansive options for test customization and clinically actionable results. Fulgent Genetics' current test menu includes more than 18,000 single-gene tests and more than 200 pre-established, multi-gene, disease-specific panels that collectively test for more than 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ZTO Express (ZTO) IPO Opens Lower
- Agree Realty (ADC) Prices Upside Stock Offering
- Snapchat Said to Seek to Raise as Much as $4B in IPO - Bloomberg
Create E-mail Alert Related CategoriesIPOs
Related EntitiesCredit Suisse, Piper Jaffray, Raymond James, IPO, BTIG
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!